• ²¹¹At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation
• A cross-sectional study on clinical characteristics and severity of children with COVID-19 admitted to a teaching institute in North India
• A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors
• A Unique Comprehensive Model to Screen Newborns for Severe Combined Immunodeficiency-An Ontario Single-Centre Experience Spanning 2013-2023
• Absolute Lymphocyte Count: a Predictor of Positive Serum PCR for Trypanosoma cruzi in Patients with Chagas Disease Undergoing Heart Transplantation
• Activation of autoreactive lymphocytes in the lung by radioresistant cells expressing a STING gain-of-function mutation
• Activation of autoreactive lymphocytes in the lung by STING gain-of-function mutation expressing radioresistant cells
• Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group
• Age-dependent decrease of circulating T follicular helper cells correlates with disease severity in elderly patients with COVID-19
• Age, gender, and infectious status-wise assessments of hematological parameters among patients with dengue infection
• Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis
• Analysis of Clinical Criteria for Discharge Among Patients Hospitalized for COVID-19: Development and Validation of a Risk Prediction Model
• Analysis of early warning indicators of death in patients with severe fever with thrombocytopenia syndrome
• Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
• Anti-IL12p40 autoantibodies in a teenage girl with multiple recurrent abscesses
• Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
• Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
• B cell depletion for autoimmune liver diseases: A retrospective review of indications and outcomes
• Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
• Case report: Disseminated <em>Cladophialophora bantiana</em> phaeohyphomycosis in a dog with hepatic dysfunction, and concurrent ehrlichiosis
• CHOLECYSTECTOMY WITH INTRAOPERATIVE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: DOES THE ORDER MATTER?
• Clinical manifestations and immune markers of non-HIV-related CMV retinitis
• Clinical Profiles, Laboratory Biomarkers, and Mortality in Cancer Patients with Lower Respiratory Tract Infections: A Prospective Cohort Study
• Comprehensive exploration of FCHO1 mutations: Clinical manifestations and implications across disorders
• Corrigendum: Epigenetic immune monitoring for COVID-19 disease course prognosis
• Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis
• COVID-19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T-cells
• Craniospinal irradiation for leptomeningeal metastasis of solid tumors: survival analysis and prognostic factors
• Cytokine profile of anti-spike CD4⁺T cells predicts humoral and CD8⁺T cell responses after anti-SARS-CoV-2 mRNA vaccination
• Cytokine Storm and Sepsis-Induced Multiple Organ Dysfunction Syndrome
• Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors
• Disseminated histoplasmosis mimicking post-vaccination side effects in an immunocompromised person with multiple sclerosis
• Distinguishing features of COVID-19 and non-COVID-19 febrile seizures in hospitalised children
• Dynamics and predictors of hematologic toxicity during cranio-spinal irradiation
• Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer
• Editorial: Updates on radiation-induced lymphopenia
• Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial
• Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency
• Experience in the use of cladribine for the treatment of patients with highly active forms of multiple sclerosis in the Moscow region
• FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
• First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
• Frequency and clinical impact of viraemia in paediatric patients undergoing therapy for cancer
• Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand Therapy
• Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction
• Hematological manifestation of Pediatric Systemic Lupus Erythematosus (SLE) - A single centered cross-sectional study
• Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine
• Hyaluronic acid impacts hematological endpoints and spleen histological features in African catfish (Clarias gariepinus)
• Icanbelimod (CBP-307), a next-generation Sphingosine-1-phosphate receptor modulator, in healthy men: pharmacokinetics, pharmacodynamics, safety, and tolerability in a randomized trial in Australia
• Immune dysregulation due to bi-allelic mutation of the actin remodeling protein DIAPH1
• Immune reconstitution in rheumatic disease patients after autologous hematopoietic stem cell transplantation
• Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Excretion in an Infant with Severe Combined Immune Deficiency with Spillover to a Parent
• Immunological and Haematological Relevance of Helminths and <em>Mycobacterium tuberculosis</em> Complex Coinfection among Newly Diagnosed Pulmonary Tuberculosis Patients from Bobo-Dioulasso, Burkina Faso
• Impact of baseline lymphopenia on outcomes of definitive treatment for locally advanced cervical cancer
• Impact of intensity-modulated proton therapy in reducing radiation-induced lymphopenia in glioma patients
• Incidence of secondary bacterial infections and risk factors for in-hospital mortality among coronavirus disease 2019 subjects admitted to secondary care hospital: A single-center cross-sectional retrospective study
• Inter-subject cerebrovascular variability: a source of uncertainty for dose calculation to circulating blood cells for glioblastoma patients treated with modern radiotherapy techniques
• Intestinal lymphangiectasia: Understanding the bigger picture
• Invasive Streptococcal Infection in Children: An Italian Case Series
• Liver and Inflammatory Biomarkers Are Related to High Mortality in Hospitalized Patients with COVID-19 in Brazilian Amazon Region
• Lymphocyte as a predictor of prognosis of COVID-19 patients: A hospital-based study
• Lymphopenia in Chronic Spontaneous Urticaria is Linked to Basopenia and Eosinopenia
• Lymphopenia in the Adult Population With Fontan Physiology: A Potential New Marker for Disease Assessment
• Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study
• Methylprednisolone induced morning lymphocytosis: A prospective study in patients with immune mediated inflammatory disorders
• MHC class II deficiency: Clinical, immunological, and genetic insights in a large multicenter cohort
• Miliary TB and COVID-19 Coinfection in a Patient With a History of Post-polycythemia Vera Myelofibrosis Treated With Ruxolitinib: A Case Report
• Model of Accelerated Aging in CB6F2 Mice Induced by Ionizing Radiation
• Modulation of Ionizing Radiation-Induced Apoptosis by Taurine in Human Peripheral Blood Lymphocytes: Flow Cytometry-based Quantification
• Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients
• Mortality risk factors in children with influenza-associated encephalopathy admitted to the paediatric intensive care unit between 2009 and 2021
• mTOR aggravated CD4⁺ T cell pyroptosis by regulating the PPARγ-Nrf2 pathway in sepsis
• Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency
• Normal mean platelet volume and thrombocytopenia: It may still be Wiskott-Aldrich syndrome
• Outbreaks of nosocomial feline calicivirus-associated virulent systemic disease in Korea
• Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations
• Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC)
• Potential Mechanisms Underlying COVID-19-Mediated Central and Peripheral Demyelination: Roles of the RAAS and ADAM-17
• Predicting COVID 19-Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study
• Profound T Lymphocyte and DNA Repair Defect Characterizes Schimke Immuno-Osseous Dysplasia
• Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
• Revealing the effect of X-ray or proton brain irradiation on systemic inflammation and leukocyte subpopulation interplay in rodents
• Risk factors for prolonged infection and secondary infection in pediatric severe sepsis
• Risk factors for uveitis in a Finnish sarcoid population
• Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database
• SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
• Severe COVID-19 in HIV/Leishmania infantum coinfected patient: a successfully managed case report
• Siponimod following Alemtuzumab in secondary progressive MS: investigating sequential therapy-A case series
• Systemic Candida abscess after hypofractionated radiotherapy with temozolomide for glioblastoma in an older patient: illustrative case
• The different paradigms of NK cell death in patients with severe trauma
• The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancer
• The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies
• The impact of different modalities of chemoradiation therapy and chemotherapy regimens on lymphopenia in patients with locally advanced non-small cell lung cancer
• The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma
• The role of clinical and laboratory finding in the differential diagnosis of Hantavirus and Leptospirosis infections
• The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis
• Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial
• Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans
• Unveiling Immunological Signatures and Predictors of Response to Immunosuppressive Therapy in Acquired Aplastic Anaemia"
• Worsening of lymphopenia in patients with multiple sclerosis when switched from dimethyl fumarate to diroximel fumarate
• Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy